Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
Creager, M. A., Lüscher, T. F., of, P. W. T. A., Cosentino, F., & Beckman, J. A. (2003) · Circulation · doi:10.1161/01.cir.0000091257.27563.32 · Cited by 1,650
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
“…are crucially altered by the metabolic milieu that characterizes diabetes mellitus, tipping the delicate balance toward atheroma formation, platelet aggregation, and thrombus formation (Keen et al., 1999; Tooke and Goh, 1999; De Vriese et al., 2000; Schaper et al., 2000; Standl and Schnell, 2000).”
BackgroundThe progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Cade, W. T. (2008) · Physical Therapy · doi:10.2522/ptj.20080008 · Cited by 1,084
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
“The endotheliumdependent relaxations to acetylcholine are blunted in a number of arteries from diabetic animals (Tesfamariam 1994, De Vriese et al. 2000).”
BackgroundSelf-citationNoninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events
Oliver, J. J., & Webb, D. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000060460.52916.d6 · Cited by 823
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
Self-citationEndothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Feletou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 806
Self-citationSivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
Ceriello, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1589 · Cited by 734
“Vascular endothelial cells are an important target of hyperglycemic damage, but the mechanisms underlying this damage are not fully understood (5).”
BackgroundKolluru, G. K., Bir, S. C., & Kevil, C. G. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/918267 · Cited by 720
“Studies aimed at combination therapies could prove beneficial to enhance protection against vascular complications during diabetes.”
BackgroundEndothelial dysfunction in diabetes mellitus.
Hadi, H. A. R., & Suwaidi, J. M. S. A. (2007) · PubMed Central · Cited by 713
Role of TNF-α in vascular dysfunction
Zhang, H., Park, Y., Wu, J., Chen, X. P., Lee, S., Yang, J., Dellsperger, K. C., & Zhang, C. (2009) · Clinical Science · doi:10.1042/cs20080196 · Cited by 680
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660
Peripheral Arterial Disease in Patients With Diabetes
Marso, S. P., & Hiatt, W. R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.065 · Cited by 575
Macro‐ and microvascular endothelial dysfunction in diabetes: 糖尿病诱导的内皮细胞功能损伤
Shi, Y., & Vanhoutte, P. M. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12521 · Cited by 545
Self-citationDiabetes, oxidative stress and therapeutic strategies
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.05.017 · Cited by 530
Yan, S. F., Ramasamy, R., Naka, Y., & Schmidt, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000103862.26506.3d · Cited by 513
Platelet activation in type 2 diabetes mellitus
Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00836.x · Cited by 493
Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes
Rask-Madsen, C., & King, G. L. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0366 · Cited by 484
“Endothelium-dependent vasodilation in insulin resistance and diabetes Decreased endothelial function has been demonstrated in type”
BackgroundEndothelial Dysfunction The First Step Toward Coronary Arteriosclerosis
Vanhoutte, P. M. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1169 · Cited by 467
Self-citationPeripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes
Thiruvoipati, T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.961 · Cited by 439
Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
Horton, W. B., & Barrett, E. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa025 · Cited by 424
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
Jefferson, J. A., Shankland, S. J., & Pichler, R. H. (2008) · Kidney International · doi:10.1038/ki.2008.128 · Cited by 419
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB
Onozato, M. L., Tojo, A., Goto, A., Fujita, T., & Wilcox, C. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00123.x · Cited by 373
“Studies in the peripheral circulation of patients with diabetes, and the renal vessels of animal models, have concluded that there is a defective EDRF response to endothelial agonists such as acetylcholin”
BackgroundRamalho-Santos, J., Amaral, S., & Oliveira, P. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502398 · Cited by 359
“Nonetheless, free radicals have emerged as major players in diabetic pathophysiology with involvement in a plethora of reactions that could also affect embryos [106,107].”
BackgroundSchrijvers, B. F., De Vriese, A. S., & Flyvbjerg, A. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0018 · Cited by 353
“, NOS3-dependent) vasodilation is impaired in diabetic animal models and in humans with type 1 and 2 diabetes (242).”
BackgroundThe pathogenesis of diabetic retinopathy: old concepts and new questions
Cai, J., & Boulton, M. (2002) · Eye · doi:10.1038/sj.eye.6700133 · Cited by 344
Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
Bakker, W., Eringa, E. C., Sipkema, P., & van Hinsbergh, V. W. M. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0685-6 · Cited by 343
“Other vasodilating factors such as endothelium-derived hyperpolarization factor (EDHF) may also be altered in diabetic animals (De Vriese et al. 2000).”
BackgroundSaam, T., Hatsukami, T. S., Takaya, N., Chu, B., Underhill, H., Kerwin, W. S., Cai, J., Ferguson, M. S., & Yuan, C. (2007) · Radiology · doi:10.1148/radiol.2441051769 · Cited by 331
Pacher, P., Obrosova, I., Mabley, J., & Szabo, C. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363207 · Cited by 330
Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2022) · Molecules · doi:10.3390/molecules27030950 · Cited by 325
“The close link between diabetes and premature vascular disease is very well established [10,11].”
BackgroundSexual dysfunction in men and women with endocrine disorders
Bhasin, S., Enzlin, P., Coviello, A., & Basson, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60280-3 · Cited by 319
Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences
Beltramo, E., & Porta, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990022 · Cited by 317
“In a second phase, endothelium seems to lose its ability to induce vasodilatation, due to impaired balance between vasoconstrictors, such as endothelin-1, and vasodilators, such as NO, the concentrations of which are reduced [64].”
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Coppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., & Yorek, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1927 · Cited by 300
Cellular signaling and NO production
Michel, T., & Vanhoutte, P. M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0765-9 · Cited by 287
“Insulin resistance and diabetes cause an impairment of arterial endothelium-dependent relaxations in animals and humans, presumably due to the chronic exposure to hyperglycemia [10, 76].”
BackgroundSelf-citationBivalacqua, T. J., Usta, M. F., Champion, H. C., Kadowitz, P. J., & Hellstrom, W. J. G. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02743.x · Cited by 268
“Decreases in NO-, prostaglandin- , and EDHF-mediated responses have been shown to be involved in cardiovascular diseases related to endothelial dysfunction, and increases in responses to Ang II and ET-1 have also been implicated (Harrison, 1997; De Vriese et al, 2000).”
BackgroundIncreased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus
Cardillo, C., Campia, U., Bryant, M. B., & Panza, J. A. (2002) · Circulation · doi:10.1161/01.cir.0000032260.01569.64 · Cited by 259
Calcium‐activated potassium channels and endothelial dysfunction: therapeutic options?
Félétou, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00052.x · Cited by 244
“In these patients and in patients with type II diabetes, whether or not the various components of the endothelium-dependent vasodilatation are differentially affected by the disease is not yet known (De Vriese et al., 2000).”
BackgroundWendt, T., Tanji, N., Guo, J., Hudson, B. I., Bierhaus, A., Ramasamy, R., Arnold, B., Nawroth, P. P., Yan, S. F., D’Agati, V., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065100.17349.ca · Cited by 239
Pistrosch, F., Passauer, J., Fischer, S., Fuecker, K., Hanefeld, M., & Gross, P. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.484 · Cited by 229
“Most have described a profound impairment (9).”
ResultMaida, C. D., Daidone, M., Pacinella, G., Norrito, R. L., Pinto, A., & Tuttolomondo, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042397 · Cited by 220
Pieper, G. M. (1999) · Diabetologia · doi:10.1007/s001250051140 · Cited by 211
Importance of pericytes and mechanisms of pericyte loss during diabetic retinopathy
Ejaz, S., Chekarova, I., Ejaz, A., Sohail, A., & Lim, C. W. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00795.x · Cited by 206
Association of the VEGF Gene With Proliferative Diabetic Retinopathy But Not Proteinuria in Diabetes
Ray, D. W., Mishra, M., Ralph, S., Read, I., Davies, R., & Brenchley, P. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.861 · Cited by 201
“Diabetes leads to specific microvascular complications of retinopathy, nephropathy, and neuropathy, as well as increased risk of atherosclerosis, which may reflect underlying endothelial dysfunction (1).”
BackgroundYusuf, M., Kwong Huat, B. T., Hsu, A., Whiteman, M., Bhatia, M., & Moore, P. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.021 · Cited by 198
Cytokines and vascular reactivity in resistance arteries
Vila, E., & Salaices, M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00779.2004 · Cited by 194
“Experimental and clinical evidence for the presence of impaired endothelium-dependent vasodilatation in types 1 and 2 diabetes are widely reported (13).”
BackgroundCoenzyme Q10 improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus
Watts, G. F., Playford, D. A., Croft, K. D., Ward, N. C., Mori, T. A., & Burke, V. (2002) · Diabetologia · doi:10.1007/s00125-001-0760-y · Cited by 194
Chronic Inflammatory Diseases and Endothelial Dysfunction
Castellon, X., & Bogdanova, V. (2016) · Aging and disease · doi:10.14336/ad.2015.0803 · Cited by 191
“The atherosclerosis, which develops among these patients, is the main cause for cardiovascular morbimortality and uncontrolled chronic biological inflammation, which quickly favors endothelial dysfunction [37, 38].”
BackgroundDiabetes-enhanced Inflammation and Apoptosis—Impact on Periodontal Pathology
Graves, D. T., Liu, R., Alikhani, M., Al-Mashat, H., & Trackman, P. C. (2006) · Journal of Dental Research · doi:10.1177/154405910608500103 · Cited by 188
“…tissue, cytokine, cell death, diabetes, gingiva, hyperglycemia, infection, inflammatory, oral, periodontitis Received March 14, 2005; Accepted July 14, 2005 15 important in initiating events linked to inflammation and apoptosis (De Vriese et al., 2000; Dagher et al., 2004; Xu et al., 2004).”
BackgroundThe Placenta and Gestational Diabetes Mellitus
Gauster, M., Desoye, G., Tötsch, M., & Hiden, U. (2012) · Current Diabetes Reports · doi:10.1007/s11892-011-0244-5 · Cited by 188
“Increased NO synthesis seems to be in contrast to reduced endothelium-dependent vasodilatation observed in patients with diabetes mellitus [49, 50].”
BackgroundRentzsch, B., Todiras, M., Iliescu, R., Popova, E., Campos, L. A., Oliveira, M. L., Baltatu, O. C., Santos, R. A., & Bader, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114322 · Cited by 187
Diabetic Nephropathy: Where Hemodynamics Meets Metabolism
Forbes, J., Fukami, K., & Cooper, M. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-949721 · Cited by 183
Nitric oxide – the endothelium-derived relaxing factor and its role in endothelial functions
Bauer, V., & Sotnikova, R. (2010) · General Physiology and Biophysics · doi:10.4149/gpb_2010_04_319 · Cited by 151
Kobayashi, M., & Zochodne, D. W. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12833 · Cited by 181
Pacher, P., & Szabó, C. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1568 · Cited by 180
“This latter mechanism may represent an important additional pathway whereby PARP activation”
Impairment in Ischemia-Induced Neovascularization in Diabetes
Tamarat, R., Silvestre, J.-S., Le Ricousse-Roussanne, S., Barateau, V., Lecomte-Raclet, L., Clergue, M., Duriez, M., Tobelem, G., & Lévy, B. I. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63136-7 · Cited by 180
“We can also speculate that the role of nondiabetic BM-MNCs is likely not restricted to the restoration of vessel number in ischemic leg of diabetic mice and may have a therapeutic role in reversing the diabetes-induced changes in VEGF production or endothelial function.(16,17,22) Endogenous diabetic BM-MNCs may also l…”
BackgroundDogné, S., Flamion, B., & Caron, N. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.310839 · Cited by 177
Pannirselvam, M., Verma, S., Anderson, T. J., & Triggle, C. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704683 · Cited by 177
“Endothelial dysfunction is considered as the major risk factor for the cardiovascular complications associated with type I and type II diabetes (De Vriese et al., 2000).”
BackgroundInfluentialReduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss
Baelde, H. J., Eikmans, M., Lappin, D. W. P., Doran, P., Hohenadel, D., Brinkkoetter, P. T., van der Woude, F. J., Waldherr, R., Rabelink, T. J., de Heer, E., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002101 · Cited by 177
“Vascular endothelial cell dysfunction is a common finding in patients with type II diabetes mellitus.(7) This may be related to dysregulation of angiogenic factors, such as vascular endothelial growth factor(VEGF-A).”
BackgroundNitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes
Bitar, M. S., Wahid, S., Mustafa, S., Al-Saleh, E., Dhaunsi, G. S., & Al-Mulla, F. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.014 · Cited by 175
Bagi, Z., Koller, A., & Kaley, G. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00718.2003 · Cited by 172
“In diabetic subjects, NO mediation of vascular responses is impaired (8) primarily by the increased production of reactive oxygen species.”
BackgroundRanderia, S. N., Thomson, G. J. A., Nell, T. A., Roberts, T. J., & Pretorius, E. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0870-9 · Cited by 172
Chander, P. N., Gealekman, O., Brodsky, S. V., Elitok, S., Tojo, A., Crabtree, M., Gross, S. S., & Goligorsky, M. S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135971.88164.2c · Cited by 171
“Endothelial dysfunction is considered a major risk factor for the cardiovascular complications in diabetes (50).”
BackgroundSoriano, F. G., Virág, L., & Szabó, C. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100236 · Cited by 171
“ates a toxic oxidant species, peroxynitrite (see below) [1, 2, 3, 4, 5].”
BackgroundInfluentialO-GlcNAc modification, insulin signaling and diabetic complications
Issad, T., Masson, E., & Pagesy, P. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.001 · Cited by 170
“Indeed, an 8-hours ntravenous infusion of glucosamine in rats induced significant ancreatic -cell apoptosis [63].”
BackgroundMetformin restores endothelial function in aorta of diabetic rats
Sena, C. M., Matafome, P., Louro, T., Nunes, E., Fernandes, R., & Seiça, R. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01230.x · Cited by 170
“Type 2 diabetes alters the vascular responsiveness to several vasoconstrictors and vasodilators and is a major factor underlying development of cardiovascular disease (De Vriese et al., 2000a).”
BackgroundDiabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes
Tuttolomondo, A., Maida, C. D., & Pinto, A. V. (2015) · World Journal of Orthopedics · doi:10.5312/wjo.v6.i1.62 · Cited by 171
Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction
Szabo, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00086.x · Cited by 165
“…Pharmacological Society All rights reserved 0007-1188/09 www.brjpharmacol.org disease (Oyama et al., 1986; Meraji et al., 1987; Mayhan, 1989; Cosentino and Luscher, 1998; De Vriese et al., 2000) and in human studies (Caballero et al., 1999; Calles-Escandon and Cipolla, 2001; Avogaro et al., 2006).”
BackgroundEndothelium‐dependent contractions: when a good guy turns bad!
Vanhoutte, P. M., & Tang, E. H. C. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.161430 · Cited by 164
“The endothelium-dependent relaxations to acetylcholine are blunted in a number of arteries from diabetic animals (see Tesfamariam, 1994; De Vriese et al. 2000).”
BackgroundSelf-citationEbrahimian, T. G., Heymes, C., You, D., Blanc-Brude, O., Mees, B., Waeckel, L., Duriez, M., Vilar, J., Brandes, R. P., Levy, B. I., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060042 · Cited by 163
“A considerable body of evidence implicates oxidative stress as an important pathogenic element in diabetic endothelial dysfunction.(30) The chronic treatment of diabetic animals with NAC improved or normalized endothelium-dependent responses.”
BackgroundYang, D., Félétou, M., Boulanger, C. M., Wu, H., Levens, N., Zhang, J., & Vanhoutte, P. M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704669 · Cited by 162
“This dysfunction is characterized by impaired relaxation in response to endothelium-dependent dilators such as acetylcholine (De Vriese et al., 2000; Taddei et al., 1993; Wolin, 2000).”
BackgroundSelf-citationOral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus
Beckman, J. A., Goldfine, A. B., Gordon, M. B., Garrett, L. A., Keaney, J. F., & Creager, M. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00403.2003 · Cited by 147
“An important contributor to the decrease in bioavailable NO is the heightened production of oxygen-derived free radicals, primarily superoxide anion (10).”
BackgroundEndothelium‐dependent hyperpolarizations: Past beliefs and present facts
Félétou, M., & Vanhoutte, P. M. (2007) · Annals of Medicine · doi:10.1080/07853890701491000 · Cited by 159
“In these patients and in patients with type II diabetes, whether or not the various components of the endothelium-dependent vasodilatation are differentially affected by the disease is not yet known (1,206).”
BackgroundSelf-citationZehetner, C., Kirchmair, R., Huber, S., Kralinger, M. T., & Kieselbach, G. F. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302451 · Cited by 159
Eid, H. M. A., Arnesen, H., Hjerkinn, E. M., Lyberg, T., & Seljeflot, I. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.026 · Cited by 158
Obesity-hypertension: an ongoing pandemic
Francischetti, E. A., & Genelhu, V. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01262.x · Cited by 157
Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery
Wigg, S. J., Tare, M., Tonta, M. A., O’Brien, R. C., Meredith, I. T., & Parkington, H. C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h232 · Cited by 156
“THE ENDOTHELIUM is an important modulator of vascular smooth muscle tone and reactivity (8), and there is broad consensus that endothelial vasodilator dysfunction may contribute to the widespread vascular complications of diabetes mellitus (5).”
BackgroundOlesen, P., Ledet, T., & Rasmussen, L. M. (2005) · Diabetologia · doi:10.1007/s00125-004-1652-8 · Cited by 152
“Several potentially pre-atherosclerotic alterations delineate the macroangiopathy, which comprises histomorphometric changes [2], matrix alterations [3, 4], accumulation of glycated proteins [5], endothelial dysfunction [6], altered biomechanical properties [7] and medial calcifications [8].”
BackgroundRole of the Schwann cell in diabetic neuropathy
Eckersley, L. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)50081-7 · Cited by 152
Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease
Heine, R. J., & Dekker, J. M. (2002) · Diabetologia · doi:10.1007/s00125-001-0726-0 · Cited by 152
Kohli, R., Meininger, C. J., Haynes, T. E., Wene, Y. A. N., Self, J. T., & Wu, G. (2004) · Journal of Nutrition · doi:10.1093/jn/134.3.600 · Cited by 151
Bagi, Z. A., Erdei, N., Tóth, A., Li, W., Hintze, T. H., Koller, Á., & Kaley, G. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172688.26838.9f · Cited by 151
eNOS Deficiency Predisposes Podocytes to Injury in Diabetes
Yuen, D. A., Stead, B. E., Zhang, Y., White, K., Kabir, M. G., Thai, K., Advani, S. L., Connelly, K. A., Takano, T., Zhu, L., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121170 · Cited by 149
“In attempting to elucidate the role of eNOS in both glomerular capillary growth and podocyte structure/function in diabetes, the following fourmajor observationsweremade: (1) the antialbuminuric effects of anti-VEGF agents in diabetes are eNOS dependent; (2) in contrast, both glomerular capillary growth and its respon…”
BackgroundNitrosative Stress and Pathogenesis of Insulin Resistance
Kaneki, M., Shimizu, N., Yamada, D., & Chang, K. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1464 · Cited by 132
Kardeşler, L., Buduneli, N., Çetinkalp, Ş., & Kinane, D. F. (2010) · Journal of Periodontology · doi:10.1902/jop.2009.090267 · Cited by 149
The vascular endothelium: A regulator of arterial tone and interface for the immune system
Khaddaj‐Mallat, R., John, C. M., Kendrick, D. J., & Braun, A. P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1394267 · Cited by 148
Anti-Inflammatory Properties of Sirtuin 6 in Human Umbilical Vein Endothelial Cells
Lappas, M. (2012) · Mediators of Inflammation · doi:10.1155/2012/597514 · Cited by 139
“…Properties of Sirtuin 6 in Human Umbilical Vein Endothelial Cells Martha Lappas1, 2 1 Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia 2 Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, VIC 3084,…”
BackgroundInfluentialAzimi, P., Ghiasvand, R., Feizi, A., Hosseinzadeh, J., Bahreynian, M., Hariri, M., & Khosravi-Boroujeni, H. (2016) · Blood Pressure · doi:10.3109/08037051.2015.1111020 · Cited by 131
“Endothelial dysfunction plays a critical role in the pathogenesis of the vascular complications of diabetes.[24] Increased levels of sICAM-1 have been shown in diabetic patients.”
BackgroundEtten, R. V., de Koning, E. J. P., Verhaar, M. C., Gaillard, S., & Rabelink, T. J. (2002) · Diabetologia · doi:10.1007/s00125-002-0862-1 · Cited by 146
“With regard to increased breakdown of NO, several mechanisms have been suggested to contribute to increased oxygen radical formation in diabetes [29].”
BackgroundEndothelial Dysfunction in Diabetes Mellitus: Possible Involvement of Endoplasmic Reticulum Stress?
Basha, B., Samuel, S. M., Triggle, C. R., & Ding, H. (2012) · Experimental Diabetes Research · doi:10.1155/2012/481840 · Cited by 131
Imbalance of angiogenesis in diabetic complications: The mechanisms
Tahergorabi, Z., & Khazaei, M. (2012) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.104853 · Cited by 144
“Also there is in type 2 diabetes reduction of endothelium derived NO.”
BackgroundBiochemical Factors Modulating Female Genital Sexual Arousal Physiology
Traish, A. M., Botchevar, E., & Kim, N. N. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01903.x · Cited by 143
Bivalacqua, T. J., Usta, M. F., Kendirci, M., Pradhan, L., Alvarez, X. A., Champion, H. C., Kadowitz, P. J., & Hellstrom, W. J. G. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.20228_1.x · Cited by 143
The Endothelium in Health and Disease-A Target for Therapeutic Intervention.
Triggle, C. R., Hollenberg, M., Anderson, T. J., Ding, H., Jiang, Y., Ceroni, L., Wiehler, W. B., Ng, E. S. M., Ellis, A., Andrews, K., et al. (2003) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.39.249 · Cited by 119
“A reduced vasodilatory response to acetylcholine has been frequently reported in vascular tissue from both humans and animals with diabetes (De Vriese et al., 2000; Pannirselvam et al., 2003) and this observation defines “endothelial dysfunction”.”
BackgroundSchneider, A. E., Neas, L., Herbst, M., Case, M., Williams, R. W., Cascio, W. E., Hinderliter, A. L., Holguín, F., Buse, J. B., Dungan, K. M., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11666 · Cited by 141
Approaches to prevention of cardiovascular complications and events in diabetes mellitus
Coccheri, S. (2007) · Drugs · doi:10.2165/00003495-200767070-00005 · Cited by 139
Durante, W., Behnammanesh, G., & Peyton, K. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168786 · Cited by 139
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.